SLC6A3 and Parkinson disease: Meanwhile, positron emission tomography (PET) and single-photon emission computed tomography (SPECT) examinations of PD patients’ dopaminergic neurons have revealed a gradual loss of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2).